22 Einträge gefunden

1. ABC6 Consensus: Assessment by a Group of German Experts

   1. Lüftner, Diana
   2. Fasching, Peter A
   3. Haidinger, Renate
   4. Harbeck, Nadia
   5. Jackisch, Christian
   6. Müller, Volkmar
   7. Schumacher-Wulf, Eva

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Advanced Breast Cancer:AGO Recommendations 2022 - Focus on ABC6 Consensus

   1. Untch, Michael
   2. Fasching, Peter A
   3. Haidinger, Renate
   4. Harbeck, Nadia
   5. Jackisch, Christian
   6. Lüftner, Diana
   7. Müller, Volkmar

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022

   1. Ditsch, Nina
   2. Wöcke, Achim
   3. Untch, Michael
   4. Jackisch, Christian
   5. Albert, Ute-Susann
   6. Banys-Paluchowski, Maggie
   7. Bauerfeind, Ingo

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients

   1. Lux, Michael P
   2. Schneeweiss, Andreas
   3. Hartkopf, Andreas D
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Belleville, Erik
   7. Stickeler, Elmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

   1. Jurmeister, Philipp
   2. Weber, Karsten
   3. Villegas, Sonia
   4. Karn, Thomas
   5. Untch, Michael
   6. Thieme, Anne
   7. Müller, Volkmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference

   1. Untch, Michael
   2. Fasching, Peter A
   3. Brucker, Sara Y
   4. Budach, Wilfried
   5. Denkert, Carsten
   6. Haidinger, Renate
   7. Huober, Jens

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials

   1. Furlanetto, Jenny
   2. Marmé, Frederik
   3. Seiler, Sabine
   4. Thode, Christian
   5. Untch, Michael
   6. Schmatloch, Sabine
   7. Schneeweiss, Andreas

   2021 - Forschungsinformationssystem des UKE
8. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

   1. Sinn, Bruno V
   2. Loibl, Sibylle
   3. Hanusch, Claus A
   4. Zahm, Dirk-Michael
   5. Sinn, Hans-Peter
   6. Untch, Michael
   7. Weber, Karsten

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
9. ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019:Commentary by the German panel of experts on the ABC5 voting results

   1. Untch, Michael
   2. Würstlein, Rachel
   3. Lüftner, Diana
   4. Haidinger, Renate
   5. Fasching, Peter A
   6. Augustin, Doris
   7. Briest, Susanne

   2020 - Forschungsinformationssystem des UKE
10. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer:Update 2020

    1. Ditsch, Nina
    2. Untch, Michael
    3. Kolberg-Liedtke, Cornelia
    4. Jackisch, Christian
    5. Krug, David
    6. Friedrich, Michael
    7. Janni, Wolfgang

    2020 - Forschungsinformationssystem des UKE
11. International Consensus Conference for Advanced Breast Cancer, Lisbon 2019:ABC5 Consensus - Assessment by a German Group of Experts

    1. Thomssen, Christoph
    2. Lüftner, Diana
    3. Untch, Michael
    4. Haidinger, Renate
    5. Würstlein, Rachel
    6. Harbeck, Nadia
    7. Augustin, Doris

    2020 - Forschungsinformationssystem des UKE
12. Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians

    1. Gass, Paul
    2. Untch, Michael
    3. Müller, Volkmar
    4. Möbus, Volker
    5. Thomssen, Christoph
    6. Häberle, Lothar
    7. Erber, Ramona

    2018 - Forschungsinformationssystem des UKE
13. ABC4 Consensus: Assessment by a German Group of Experts

    1. Harbeck, Nadia
    2. Lüftner, Diana
    3. Marschner, Norbert
    4. Untch, Michael
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
14. 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts

    1. Untch, Michael
    2. Würstlein, Rachel
    3. Marschner, Norbert
    4. Lüftner, Diana
    5. Augustin, Doris
    6. Briest, Susanne
    7. Ettl, Johannes

    2018 - Forschungsinformationssystem des UKE
15. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)

    1. Untch, Michael
    2. Huober, Jens
    3. Jackisch, Christian
    4. Schneeweiss, Andreas
    5. Brucker, Sara Y
    6. Dall, Peter
    7. Denkert, Carsten

    2017 - Forschungsinformationssystem des UKE
16. Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study

    1. Hein, Alexander
    2. Lambrechts, Diether
    3. von Minckwitz, Gunter
    4. Häberle, Lothar
    5. Eidtmann, Holger
    6. Tesch, Hans
    7. Untch, Michael

    2015 - Forschungsinformationssystem des UKE
17. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

    1. Müller, Volkmar
    2. Gade, Stephan
    3. Steinbach, Bettina
    4. Loibl, Sibylle
    5. von Minckwitz, Gunter
    6. Untch, Michael
    7. Schwedler, Kathrin

    2014 - Forschungsinformationssystem des UKE
18. HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

    1. Harbeck, Nadia
    2. Beckmann, Matthias W
    3. Rody, Achim
    4. Schneeweiss, Andreas
    5. Müller, Volkmar
    6. Fehm, Tanja
    7. Marschner, Norbert

    2013 - Forschungsinformationssystem des UKE
19. Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment

    1. de Wit, Maike
    2. Ortner, Petra
    3. Lipp, Hans-Peter
    4. Sehouli, Jalid
    5. Untch, Michael
    6. Ruhnke, Markus
    7. Mayer-Steinacker, Regine

    2013 - Forschungsinformationssystem des UKE
20. German adjuvant intergroup node-positive study:a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer

    1. von Minckwitz, Gunter
    2. Möbus, Volker
    3. Schneeweiss, Andreas
    4. Huober, Jens
    5. Thomssen, Christoph
    6. Untch, Michael
    7. Jackisch, Christian

    2013 - Forschungsinformationssystem des UKE